Evidence map›Paper›PMID 22098709›Full record

ArticleBMC molecular biology2011

Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assays.

Jingjing Yu, Qinghua Feng, Yusong Ruan, Radko Komers, Nancy Kiviat, Karol Bomsztyk

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in BMC molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.Laboratory investigation; a journal of technical methods and pathology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Single cell epigenetic visualization assay.Nucleic acids research · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jingjing YuUW Medicine Lake Union, University of Washington, Seattle, WA 98109, USA.
Qinghua Feng
Yusong Ruan
Radko Komers
Nancy Kiviat
Karol Bomsztyk
Union University · USUniversity of Washington · USOregon Health & Science University · US

Funding

LAMININ GENE EXPRESSION IN GLOMERULAR CELLSR37DK045978 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2003 to 2011
$2.2M
Acute Renal Failure: An Endotoxin Hyper-Responsive StateR01DK083310 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL, ZAGER, RICHARD A. · 2010 to 2013
$1.5M
Epigenetic changes predict disease course of HPV-related lesions in women 16-24R01CA141018 · NCI · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL, KIVIAT, NANCY B. · 2009 to 2010
$1.3M
NCI NIH HHS R01 CA141018NIDDK NIH HHS R01 DK083310NIDDK NIH HHS R37 DK45978
6 · The paper itself

Abstract

backgroundThe processes that compose expression of a given gene are far more complex than previously thought presenting unprecedented conceptual and mechanistic challenges that require development of new tools. Chromatin structure, which is regulated by DNA methylation and histone modification, is at the center of gene regulation. Immunoprecipitations of chromatin (ChIP) and methylated DNA (MeDIP) represent a major achievement in this area that allow researchers to probe chromatin modifications as well as specific protein-DNA interactions in vivo and to estimate the density of proteins at specific sites genome-wide. Although a critical component of chromatin structure, DNA methylation has often been studied independently of other chromatin events and transcription.

resultsTo allow simultaneous measurements of DNA methylation with other genomic processes, we developed and validated a simple and easy-to-use high throughput microplate-based platform for analysis of DNA methylation. Compared to the traditional beads-based MeDIP the microplate MeDIP was more sensitive and had lower non-specific binding. We integrated the MeDIP method with a microplate ChIP assay which allows measurements of both DNA methylation and histone marks at the same time, Matrix ChIP-MeDIP platform. We illustrated several applications of this platform to relate DNA methylation, with chromatin and transcription events at selected genes in cultured cells, human cancer and in a model of diabetic kidney disease.

conclusionThe high throughput capacity of Matrix ChIP-MeDIP to profile tens and potentially hundreds of different genomic events at the same time as DNA methylation represents a powerful platform to explore complex genomic mechanism at selected genes in cultured cells and in whole tissues. In this regard, Matrix ChIP-MeDIP should be useful to complement genome-wide studies where the rich chromatin and transcription database resources provide fruitful foundation to pursue mechanistic, functional and diagnostic information at genes of interest in health and disease.

Indexed as

AnimalsCell LineChromatinChromatin ImmunoprecipitationDNADNA MethylationHigh-Throughput Screening AssaysHumansMaleMiceMice, Inbred C57BLProteinsChromatinDNAProteins

Identifiers

PMID22098709
PMCPMC3247195
OpenAlexW1999056245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.